Q4 2025 Holdings
Filed 2026-02-17 | 15 holdings | $770.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Johnson & Johnson(JNJ) | COM | 478160104 | $124.8M | 603,143 | 16.2% |
| Danaher Corporation(DHR) | COM | 235851102 | $79.4M | 346,875 | 10.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $68.0M | 63,284 | 8.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $58.9M | 120,921 | 7.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $56.5M | 265,015 | 7.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $50.1M | 86,023 | 6.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $49.6M | 520,508 | 6.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $44.8M | 1,435,865 | 5.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $44.1M | 557,174 | 5.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $40.8M | 805,689 | 5.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $36.8M | 201,627 | 4.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $31.7M | 37,653 | 4.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $30.9M | 307,371 | 4.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $28.0M | 421,600 | 3.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $25.6M | 622,403 | 3.3% |